Acadia Pharmaceuticals Inc
ACAD· Nasdaq
ACADAcadia Pharmaceuticals Inc
Released Jul 31, 2019, after the close
10-Q filed Aug 1, 2019, 32 days after period end · 0001564590-19-027565
| Metric | Q2 2019 | Q2 2018 | Q2 2017 | Q2 2016 |
|---|---|---|---|---|
| Revenue | $83.21M | $57.06M | $30.48M | $97.00K |
| Net Income | -$54.94M | -$63.27M | -$67.44M | -$71.32M |
| EPS Diluted |
Acadia Pharmaceuticals Inc · CIK 1070494 · Engraved from SEC EDGAR
| -$0.38 |
| -$0.51 |
| -$0.55 |
| -$0.63 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
